• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

2

CATEGORIES

  • 20
  • 8
  • 5
  • 2
  • 2
  • 1

PRICE

2
3
5
38

PUBLISHED

0
3
23
38

PRODUCT TYPE

36
2

Search "ProMetic Life Sciences Inc.-Therapeutic Competitors Report" returned 38 results.

PRODUCT TITLE
Competitor Analysis: Erythropoietin (EPO) Competitor Analysis: Erythropoietin (EPO) - Product Thumbnail Image

Competitor Analysis: Erythropoietin (EPO)

The Competitive Intelligence Report Erythropoietin (EPO) & Erythropoiesis Stimulating Agents (ESA) as of January 2011 in its 5th edition provides information on existing first and second generation...

January 2011
FROM

Bioseparation Systems for Global Biopharmaceutical Markets

Bioseparations systems can be categorized into three types: chromatography, membranes/filters and centrifuges The demand for single use products is increasing and fueling growth of the global bioseparations...

August 2013
FROM
Commercializing Pancreatic Cancer Drugs in Cancer: The Faster Route to Consider Your Options and Position of Others Commercializing Pancreatic Cancer Drugs in Cancer: The Faster Route to Consider Your Options and Position of Others - Product Thumbnail Image

Commercializing Pancreatic Cancer Drugs in Cancer: The Faster Route to Consider Your Options and Position of Others

This report will excel your competitive awareness and decrease your decision making time in managing pancreatic cancer drug development Find out whether you are number one, two or further down the ladder...

March 2012
FROM

Octapharma AG - Strategic SWOT Analysis Review

Octapharma AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT...

April 2015
FROM

Hyperlipidemia - Pipeline Review, H2 2014

Hyperlipidemia - Pipeline Review, H2 2014 Summary This, ‘Hyperlipidemia - Pipeline Review, H2 2014’, provides an overview of the Hyperlipidemia’s therapeutic pipeline. This report provides comprehensive...

October 2014
FROM

Liver Fibrosis - Pipeline Review, H1 2014

Liver Fibrosis - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Liver Fibrosis - Pipeline Review, H1 2014’, provides an overview of the Liver Fibrosis’s therapeutic pipeline. This report...

April 2014
FROM

Liver Fibrosis - Pipeline Review, H2 2014

Liver Fibrosis - Pipeline Review, H2 2014 Summary This, ‘Liver Fibrosis - Pipeline Review, H2 2014’, provides an overview of the Liver Fibrosis’s therapeutic pipeline. This report provides comprehensive...

October 2014
FROM

Sartorius Stedim Biotech S.A. (DIM) - Financial and Strategic SWOT Analysis Review

Sartorius Stedim Biotech S.A. (DIM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled...

June 2014
FROM

Liver Fibrosis - Pipeline Review, H1 2015

Liver Fibrosis - Pipeline Review, H1 2015 Summary This, ‘Liver fibrosis - Pipeline Review, H1 2015’, provides an overview of the Liver fibrosis’s therapeutic pipeline. This report provides comprehensive...

February 2015
FROM

Kidney Fibrosis - Pipeline Review, H2 2014

Kidney Fibrosis - Pipeline Review, H2 2014 Summary This, ‘Kidney Fibrosis - Pipeline Review, H2 2014’, provides an overview of the Kidney Fibrosis’s therapeutic pipeline. This report provides comprehensive...

July 2014
FROM

Kidney Fibrosis - Pipeline Review, H1 2014

Kidney Fibrosis - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Kidney Fibrosis - Pipeline Review, H1 2014’, provides an overview of the Kidney Fibrosis’s therapeutic pipeline. This...

February 2014
FROM

Neutropenia - Pipeline Review, H1 2014

Neutropenia - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Neutropenia - Pipeline Review, H1 2014’, provides an overview of the Neutropenia’s therapeutic pipeline. This report provides...

March 2014
FROM

Primary Immune Deficiency (PID) - Pipeline Review, H2 2014

Primary Immune Deficiency (PID) - Pipeline Review, H2 2014 Summary This, ‘Primary Immune Deficiency (PID) - Pipeline Review, H2 2014’, provides an overview of the Primary Immune Deficiency (PID)’s...

December 2014
FROM

Pulmonary Fibrosis - Pipeline Review, H1 2015

Pulmonary Fibrosis - Pipeline Review, H1 2015 Summary This, ‘Pulmonary Fibrosis - Pipeline Review, H1 2015’, provides an overview of the Pulmonary Fibrosis’s therapeutic pipeline. This report provides...

January 2015
FROM

Pulmonary Fibrosis - Pipeline Review, H2 2014

Pulmonary Fibrosis - Pipeline Review, H2 2014 Summary This, ‘Pulmonary Fibrosis - Pipeline Review, H2 2014’, provides an overview of the Pulmonary Fibrosis’s therapeutic pipeline. This report provides...

December 2014
FROM

Chemotherapy Induced Anemia - Pipeline Review, H2 2014

Chemotherapy Induced Anemia - Pipeline Review, H2 2014 Summary This, ‘Chemotherapy Induced Anemia - Pipeline Review, H2 2014’, provides an overview of the Chemotherapy Induced Anemia’s therapeutic...

August 2014
FROM

Chemotherapy Induced Anemia - Pipeline Review, H1 2014

Chemotherapy Induced Anemia - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Chemotherapy Induced Anemia - Pipeline Review, H1 2014’, provides an overview of the Chemotherapy Induced Anemia’s...

March 2014
FROM

Chemotherapy Induced Anemia - Pipeline Review, H1 2015

Chemotherapy Induced Anemia - Pipeline Review, H1 2015 Summary This ‘Chemotherapy Induced Anemia - Pipeline Review, H1 2015’, provides an overview of the Chemotherapy Induced Anemia’s therapeutic...

February 2015
FROM

Diabetic Nephropathy - Pipeline Review, H1 2015

Diabetic Nephropathy - Pipeline Review, H1 2015 Summary This, ‘Diabetic Nephropathy - Pipeline Review, H1 2015’, provides an overview of the Diabetic Nephropathy’s therapeutic pipeline. This report...

January 2015
FROM

Non-Alcoholic Steatohepatitis - Pipeline Review, H2 2014

Non-Alcoholic Steatohepatitis - Pipeline Review, H2 2014 Summary This, ‘Non-Alcoholic Steatohepatitis - Pipeline Review, H2 2014’, provides an overview of the Non-Alcoholic Steatohepatitis’s therapeutic...

September 2014
FROM
Loading Indicator

Our Clients

Hexcel Corporation Harrods Ltd. Bayer AG Google, Inc. Boeing Company Harley Davidson Motor Company SwissCom AG